��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
諾貝兒(6844)
月營收
季盈餘
2025/04/01
110.5元 (諾貝兒股價)
2025/04/01
0.61% (年增率)
274百萬元 (營收)
諾貝兒(6844) 年度營收走勢圖
諾貝兒(6844)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/04
273,539
-2.98%
271,892
0.61%
1,144,254
2.63%
114/03
281,934
1.68%
271,963
3.67%
870,715
3.28%
114/02
277,288
-10.98%
291,411
-4.85%
588,781
3.09%
114/01
311,493
3.49%
279,705
11.36%
311,493
11.36%
113/12
300,985
7.98%
298,283
0.91%
3,399,813
-5.62%
113/11
278,748
1.07%
271,891
2.52%
3,098,828
-6.21%
113/10
275,788
-1.05%
289,703
-4.80%
2,820,080
-6.99%
113/09
278,712
-3.17%
277,630
0.39%
2,544,292
-7.22%
113/08
287,824
3.03%
303,632
-5.21%
2,265,581
-8.08%
113/07
279,366
0.85%
302,035
-7.51%
1,977,757
-8.48%
113/06
277,010
-9.60%
294,782
-6.03%
1,698,391
-8.64%
113/05
306,411
12.70%
323,712
-5.34%
1,421,381
-9.13%
113/04
271,892
-0.03%
296,552
-8.32%
1,114,971
-10.12%
113/03
271,963
-6.67%
299,395
-9.16%
843,079
-10.68%
113/02
291,411
4.19%
290,934
0.16%
571,115
-11.39%
113/01
279,705
-6.23%
353,586
-20.89%
279,705
-20.89%
112/12
298,283
9.71%
356,507
-16.33%
3,602,136
-14.31%
112/11
271,891
-6.15%
295,697
-8.05%
3,303,853
-14.12%
112/10
289,703
4.35%
339,614
-14.70%
3,031,962
-14.62%
112/09
277,630
-8.56%
319,162
-13.01%
2,742,259
-14.62%
112/08
303,632
0.53%
333,778
-9.03%
2,464,629
-14.79%
112/07
302,035
2.46%
331,179
-8.80%
2,160,997
-15.54%
112/06
294,782
-8.94%
377,233
-21.86%
1,858,962
-16.55%
112/05
323,712
9.16%
467,113
-30.70%
1,564,179
-15.46%
112/04
296,552
-0.95%
413,164
-28.22%
1,240,467
-10.32%
112/03
299,395
2.91%
314,164
-4.70%
943,915
-2.69%
112/02
290,934
-17.72%
306,258
-5.00%
644,520
-1.73%
112/01
353,586
-0.82%
349,634
1.13%
353,586
1.13%
111/12
356,507
20.56%
327,117
8.98%
4,203,502
10.18%
111/11
295,697
-12.93%
310,277
-4.70%
3,846,995
10.30%
111/10
339,614
6.41%
339,855
-0.07%
3,551,298
11.76%
111/09
319,162
-4.38%
304,795
4.71%
3,211,684
13.18%
111/08
333,778
0.78%
322,610
3.46%
2,892,522
14.20%
111/07
331,179
-12.21%
312,979
5.82%
2,558,744
15.76%
111/06
377,233
-19.24%
315,564
19.54%
2,227,565
17.41%
111/05
467,113
13.06%
391,958
19.17%
1,850,332
16.98%
111/04
413,164
31.51%
282,084
46.47%
1,383,219
16.26%
111/03
314,164
2.58%
970,056
111/02
306,258
-12.41%
655,892
111/01
349,634
6.88%
349,634
110/12
327,117
5.43%
3,814,952
110/11
310,277
-8.70%
3,487,835
110/10
339,855
11.50%
3,177,558
110/09
304,795
-5.52%
2,837,703
110/08
322,610
3.08%
2,532,909
110/07
312,979
-0.82%
2,210,298
110/06
315,564
-19.49%
1,897,319
110/05
391,958
38.95%
1,581,755
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
